Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/85541
Title: Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
Authors: Mohammad Zarei
Barroso, Emma
Palomer, Xavier
Dai, Jianli
Rada, Patricia
Quesada-López, Tania
Escolà-Gil, Joan Carles
Cedó, Lidia
Mohammad Reza Zali
Molaei, Mahsa
Dabiri, Reza
Vázquez, Santiago
Pujol, Eugènia
Valverde, Ángela M.
Villarroya, Francesc
Liu, Yong
Wahli, Walter
Vázquez-Carrera, Manuel
Keywords: VLDLR
PPAR
Issue Date: 2017
Source: Mohammad Zarei, Barroso, E., Palomer, X., Dai, J., Rada, P., Quesada-López, T., et al. (2018). Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease. Molecular Metabolism, 8, 117-131.
Series/Report no.: Molecular Metabolism
Abstract: Objective: The very low-density lipoprotein receptor (VLDLR) plays an important role in the development of hepatic steatosis. In this study, we investigated the role of Peroxisome Proliferator-Activated Receptor (PPAR)β/δ and fibroblast growth factor 21 (FGF21) in hepatic VLDLR regulation. Methods: Studies were conducted in wild-type and Pparβ/δ-null mice, primary mouse hepatocytes, human Huh-7 hepatocytes, and liver biopsies from control subjects and patients with moderate and severe hepatic steatosis. Results: Increased VLDLR levels were observed in liver of Pparβ/δ-null mice and in Pparβ/δ-knocked down mouse primary hepatocytes through mechanisms involving the heme-regulated eukaryotic translation initiation factor 2α (eIF2α) kinase (HRI), activating transcription factor (ATF) 4 and the oxidative stress-induced nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathways. Moreover, by using a neutralizing antibody against FGF21, Fgf21-null mice and by treating mice with recombinant FGF21, we show that FGF21 may protect against hepatic steatosis by attenuating endoplasmic reticulum (ER) stress-induced VLDLR upregulation. Finally, in liver biopsies from patients with moderate and severe hepatic steatosis, we observed an increase in VLDLR levels that was accompanied by a reduction in PPARβ/δ mRNA abundance and DNA-binding activity compared with control subjects. Conclusions: Overall, these findings provide new mechanisms by which PPARβ/δ and FGF21 regulate VLDLR levels and influence hepatic steatosis development.
URI: https://hdl.handle.net/10356/85541
http://hdl.handle.net/10220/45208
ISSN: 2212-8778
DOI: 10.1016/j.molmet.2017.12.008
Rights: © 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

SCOPUSTM   
Citations 20

16
checked on Aug 31, 2020

WEB OF SCIENCETM
Citations 20

18
checked on Oct 24, 2020

Page view(s) 20

213
checked on Oct 25, 2020

Download(s) 20

40
checked on Oct 25, 2020

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.